|
COGT Cogent Biosciences Inc 1622229 |
| Balance Sheet |
|
Current Assets
|
341,528,000 |
|
Assets
|
384,016,000 |
|
Current Liabilities
|
53,048,000 |
|
Liabilities
|
69,357,000 |
|
Equity
|
314,659,000 |
|
Shares Out
|
109,450,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-147,214,000 |
|
Investing Cash Flow
|
-23,395,000 |
| Market Analysis |
Market Cap
|
1,149,229,200 |
|
Price
|
8.03 |
|
BVPS
|
2.87 |
|
PB
|
2.78 |
|
EPS
|
-2.48 |
|
PS
|
34.47 |
|
FCF
|
-170,609,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view COGT documents filed with the SEC.
COGT Filings
Clear
